<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00756977</url>
  </required_header>
  <id_info>
    <org_study_id>BLI850-301</org_study_id>
    <secondary_id>BLI850-301</secondary_id>
    <nct_id>NCT00756977</nct_id>
  </id_info>
  <brief_title>BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy</brief_title>
  <official_title>BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Braintree Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Braintree Laboratories</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA
      approved bowel preparation in adult subjects undergoing colonoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy - Preparation Quality Using a 4 Point Scale</measure>
    <time_frame>2-day</time_frame>
    <description>Percentage of patients with a successful preparation (cleaning rated as &quot;Good&quot; or &quot;Excellent&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (mg/dL)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology Results (%)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (U/L)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (mEq/L)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (g/dL)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (GFR)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology Results (1000/MCL)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology Results - Hemoglobin</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology Results - Red Blood Cells</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (Osmolality)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">394</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>multi-dose preparation for oral administration prior to colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>multi-dose preparation for oral administration prior to colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BLI850</intervention_name>
    <description>multi-dose preparation for oral administration prior to colonoscopy</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>polyethylene glycol 3350 based bowel preparation</intervention_name>
    <description>multi-dose preparation for oral administration prior to colonoscopy</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female outpatients who are undergoing colonoscopy for a routinely accepted
             indication, including:

               -  Evaluation of barium enema results

               -  GI bleeding

               -  Anemia of unknown etiology

               -  Neoplastic disease surveillance

               -  Abnormal Endosonography

               -  Inflammatory bowel disease

               -  Unknown diarrhea or constipation etiology

               -  Polypectomy

               -  Laser therapy

               -  Routine screening

          2. At least 18 years of age.

          3. Otherwise in good health, as determined by physical exam and medical history.

          4. If female, and of child-bearing potential, is using an acceptable form of birth
             control (hormonal birth control, IUD, double-barrier method, depot contraceptive,
             abstinent, or vasectomized spouse).

          5. Negative urine pregnancy test at screening, if applicable.

          6. In the Investigator's judgment, subject is mentally competent to provide informed
             consent to participate in the study.

        Exclusion Criteria:

          1. Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal
             obstruction, gastric retention, bowel perforation, toxic colitis, or megacolon.

          2. Subjects with impaired consciousness that predisposes them to pulmonary aspiration.

          3. Subjects who are undergoing colonoscopy for foreign body removal or decompression.

          4. Subjects with clinically significant electrolyte abnormalities based on Visit 1
             laboratory results.

          5. Subjects who had previous significant gastrointestinal surgeries (e.g. colostomy,
             colectomy, gastric bypass).

          6. Subjects who are pregnant or lactating, or intending to become pregnant during the
             study.

          7. Subjects of childbearing potential who refuse a pregnancy test.

          8. Subjects who are allergic to any preparation components

          9. Subjects who, in the opinion of the Investigator, should not be included in the study
             for any reason, including inability to follow study procedures.

         10. Subjects who have participated in an investigational surgical, drug, or device study
             within the past 30 days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John D McGowan</last_name>
    <role>Study Director</role>
    <affiliation>Braintree Laboratories</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of South Alabama</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36693</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jupiter Research</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Research Associates</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Medical Research</name>
      <address>
        <city>New Smyrna Beach</city>
        <state>Florida</state>
        <zip>32168</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlanta Gastroenterology Associates</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delta Research Partners</name>
      <address>
        <city>Monroe</city>
        <state>Louisiana</state>
        <zip>71201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maryland Digestive Disease Research</name>
      <address>
        <city>Laurel</city>
        <state>Maryland</state>
        <zip>20707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Island GI Research Group</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Digestive Health Associates</name>
      <address>
        <city>Harrisburg</city>
        <state>North Carolina</state>
        <zip>28075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Research Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Gastroenterology Associates of Lancaster</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southeastern Clinical Research</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2008</study_first_submitted>
  <study_first_submitted_qc>September 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2008</study_first_posted>
  <results_first_submitted>February 19, 2013</results_first_submitted>
  <results_first_submitted_qc>July 8, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 9, 2013</results_first_posted>
  <disposition_first_submitted>November 16, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>November 16, 2009</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">November 18, 2009</disposition_first_posted>
  <last_update_submitted>August 9, 2013</last_update_submitted>
  <last_update_submitted_qc>August 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>screening</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyethylene glycol 3350</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>BLI850</title>
          <description>Single administration oral preparation</description>
        </group>
        <group group_id="P2">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          <description>Single administration oral preparation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="196"/>
                <participants group_id="P2" count="198"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="175"/>
                <participants group_id="P2" count="187"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Intent to Treat population</population>
      <group_list>
        <group group_id="B1">
          <title>BLI850</title>
        </group>
        <group group_id="B2">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="176"/>
            <count group_id="B2" value="190"/>
            <count group_id="B3" value="366"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="128"/>
                    <measurement group_id="B2" value="141"/>
                    <measurement group_id="B3" value="269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.8" spread="13.1"/>
                    <measurement group_id="B2" value="56.9" spread="12.3"/>
                    <measurement group_id="B3" value="56.9" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="104"/>
                    <measurement group_id="B3" value="201"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="176"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="366"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Efficacy - Preparation Quality Using a 4 Point Scale</title>
        <description>Percentage of patients with a successful preparation (cleaning rated as &quot;Good&quot; or &quot;Excellent&quot;</description>
        <time_frame>2-day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Efficacy - Preparation Quality Using a 4 Point Scale</title>
          <description>Percentage of patients with a successful preparation (cleaning rated as &quot;Good&quot; or &quot;Excellent&quot;</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90" lower_limit="84" upper_limit="94"/>
                    <measurement group_id="O2" value="84" lower_limit="77" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (mg/dL)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <population>Intent-to-treat population: all patients that took any portion of the study preparation.</population>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (mg/dL)</title>
          <description>Change from Baseline</description>
          <population>Intent-to-treat population: all patients that took any portion of the study preparation.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Blood urea nitrogen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.08" spread="3.6"/>
                    <measurement group_id="O2" value="-3.59" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.42"/>
                    <measurement group_id="O2" value="-0.13" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.14"/>
                    <measurement group_id="O2" value="0.03" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Direct bilirubin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.05"/>
                    <measurement group_id="O2" value="0.05" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="32"/>
                    <measurement group_id="O2" value="-5.52" spread="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phosphate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.65"/>
                    <measurement group_id="O2" value="-0.02" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total bilirubin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.21"/>
                    <measurement group_id="O2" value="0.27" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="0.80"/>
                    <measurement group_id="O2" value="0.49" spread="0.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematology Results (%)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Hematology Results (%)</title>
          <description>Change from Baseline</description>
          <population>Intent to treat population</population>
          <units>standard %</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Basophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.46"/>
                    <measurement group_id="O2" value="0.07" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.95"/>
                    <measurement group_id="O2" value="-0.09" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematocrit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.50" spread="3.1"/>
                    <measurement group_id="O2" value="0.38" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" spread="7.3"/>
                    <measurement group_id="O2" value="0.44" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Monocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="1.79"/>
                    <measurement group_id="O2" value="0.07" spread="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.08" spread="8.0"/>
                    <measurement group_id="O2" value="-0.50" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (U/L)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <population>Intent-to-treat population: all patients that took any portion of the study preparation.</population>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (U/L)</title>
          <description>Change from Baseline</description>
          <population>Intent-to-treat population: all patients that took any portion of the study preparation.</population>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Alkaline Phosphatase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.46" spread="10.9"/>
                    <measurement group_id="O2" value="1.96" spread="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="8.8"/>
                    <measurement group_id="O2" value="4.20" spread="50.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Amylase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.1" spread="14.7"/>
                    <measurement group_id="O2" value="-16.5" spread="97.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.63" spread="6.5"/>
                    <measurement group_id="O2" value="2.61" spread="16.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatine kinase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.1" spread="198"/>
                    <measurement group_id="O2" value="6.2" spread="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GGT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.38" spread="11.8"/>
                    <measurement group_id="O2" value="0.73" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (mEq/L)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <population>Intent-to-treat population: all patients that took any portion of the study preparation.</population>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (mEq/L)</title>
          <description>Change from Baseline</description>
          <population>Intent-to-treat population: all patients that took any portion of the study preparation.</population>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Anion Gap</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="2.70"/>
                    <measurement group_id="O2" value="0.53" spread="2.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bicarbonate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.88" spread="2.6"/>
                    <measurement group_id="O2" value="-0.51" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63" spread="2.4"/>
                    <measurement group_id="O2" value="0.27" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.13"/>
                    <measurement group_id="O2" value="-0.03" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.19" spread="0.43"/>
                    <measurement group_id="O2" value="-0.24" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" spread="2.2"/>
                    <measurement group_id="O2" value="0.29" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (g/dL)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <population>Intent-to-treat population: all patients that took any portion of the study preparation.</population>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (g/dL)</title>
          <description>Change from Baseline</description>
          <population>Intent-to-treat population: all patients that took any portion of the study preparation.</population>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Albumin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.23"/>
                    <measurement group_id="O2" value="-0.00" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total protein</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.38"/>
                    <measurement group_id="O2" value="0.01" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (GFR)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (GFR)</title>
          <description>Change from Baseline</description>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.21" spread="14.6"/>
                    <measurement group_id="O2" value="-2.82" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematology Results (1000/MCL)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Hematology Results (1000/MCL)</title>
          <description>Change from Baseline</description>
          <population>Intent to treat population</population>
          <units>1000/MCL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Platelets</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.82" spread="36"/>
                    <measurement group_id="O2" value="-1.09" spread="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White blood cells</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.55" spread="1.6"/>
                    <measurement group_id="O2" value="-0.59" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematology Results - Hemoglobin</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Hematology Results - Hemoglobin</title>
          <description>Change from Baseline</description>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.90"/>
                    <measurement group_id="O2" value="0.20" spread="0.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematology Results - Red Blood Cells</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Hematology Results - Red Blood Cells</title>
          <description>Change from Baseline</description>
          <units>MILL/MCL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.30"/>
                    <measurement group_id="O2" value="0.04" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (Osmolality)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (Osmolality)</title>
          <description>Change from Baseline</description>
          <units>mOsm/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="190"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.88" spread="6.2"/>
                    <measurement group_id="O2" value="-0.18" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 days</time_frame>
      <desc>ITT Population - all subjects that took any portion of preparation</desc>
      <group_list>
        <group group_id="E1">
          <title>BLI850</title>
        </group>
        <group group_id="E2">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="145" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="142" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="92" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="85" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="71" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="78" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>nausea</sub_title>
                <counts group_id="E1" subjects_affected="74" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="75" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>overall discomfort</sub_title>
                <counts group_id="E1" subjects_affected="122" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="108" subjects_at_risk="190"/>
              </event>
              <event>
                <sub_title>vomiting</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="190"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extent the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John McGowan</name_or_title>
      <organization>Braintree Laboratories</organization>
      <phone>781-843-2202</phone>
      <email>jmcgowan@braintreelabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

